Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Tanner

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Tuberculosis (Edinburgh, Scotland)|June 15, 2024
Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patientsJomkwan Ongarj, Porntip Intapiboon, Smonrapat Surasombatpattana, et al.
Ebiomedicine|February 13, 2016
Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: LymphocytesVivek Naranbhai, Helen A Fletcher, Rachel Tanner, et al.
The Journal of Infectious Diseases|November 26, 2013
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combinationStephanie A Harris, Joel Meyer, Iman Satti, et al.
Tuberculosis (Edinburgh, Scotland)|June 4, 2013
Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)Leanne Marsay, Magali Matsumiya, Rachel Tanner, et al.
Vaccine|December 26, 2012
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal deliveryJoel Meyer, Stephanie A Harris, Iman Satti, et al.
Journal of Immunological Methods|February 3, 2019
Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cellsRachel Tanner, Steven G Smith, Krista E van Meijgaarden, et al.
Journal of Neuroinflammation|October 9, 2022
Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal modelTianrong Yeo, Halwan Bayuangga, Marcus Augusto-Oliveira, et al.
BMC Infectious Diseases|August 14, 2016
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosisAndrea Zelmer, Rachel Tanner, Elena Stylianou, et al.
Frontiers in Immunology|January 31, 2020
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: <i>in vitro</i> Mycobacterial Growth Inhibition Predicts Outcome of <i>in vivo</i> Mycobacterial InfectionRachel Tanner, Iman Satti, Stephanie A Harris, et al.
BMC Infectious Diseases|June 11, 2014
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell responseMagali Matsumiya, Stephanie A Harris, Iman Satti, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Tuberculosis (Edinburgh, Scotland)|June 15, 2024
Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patientsJomkwan Ongarj, Porntip Intapiboon, Smonrapat Surasombatpattana, et al.
Ebiomedicine|February 13, 2016
Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: LymphocytesVivek Naranbhai, Helen A Fletcher, Rachel Tanner, et al.
The Journal of Infectious Diseases|November 26, 2013
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combinationStephanie A Harris, Joel Meyer, Iman Satti, et al.
Tuberculosis (Edinburgh, Scotland)|June 4, 2013
Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)Leanne Marsay, Magali Matsumiya, Rachel Tanner, et al.
Vaccine|December 26, 2012
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal deliveryJoel Meyer, Stephanie A Harris, Iman Satti, et al.
Journal of Immunological Methods|February 3, 2019
Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cellsRachel Tanner, Steven G Smith, Krista E van Meijgaarden, et al.
Journal of Neuroinflammation|October 9, 2022
Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal modelTianrong Yeo, Halwan Bayuangga, Marcus Augusto-Oliveira, et al.
BMC Infectious Diseases|August 14, 2016
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosisAndrea Zelmer, Rachel Tanner, Elena Stylianou, et al.
Frontiers in Immunology|January 31, 2020
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: <i>in vitro</i> Mycobacterial Growth Inhibition Predicts Outcome of <i>in vivo</i> Mycobacterial InfectionRachel Tanner, Iman Satti, Stephanie A Harris, et al.
BMC Infectious Diseases|June 11, 2014
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell responseMagali Matsumiya, Stephanie A Harris, Iman Satti, et al.
Pageof 8